LAS VEGAS, June 7, 2017 /PRNewswire/ — Digipath, Inc. (OTCQB: DIGP), an independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that its President, Todd Denkin, will be a presenter at the Southeast Cannabis Conference on June 11, 2017, in Ft. Lauderdale, FL.

Mr. Denkin will be presenting at the session entitled, “Cannabis Testing, Safety & Analytics,” where he will be discussing the vital role that cannabis testing plays in the emerging cannabis marketplace, the value that testing and analytics provide to cannabis consumers, and the leadership role that Digipath has achieved in the market.

For more information about this event please click here https://seccexpo.com/.

Mr. Denkin commented, “Cannabis lab testing is evolving from traditional potency and pesticide testing to a focus on strain identification, data analytics and ultimately consumer protection.  Cannabis consumers should have full confidence in the “health” of the cannabis products they are consuming as well as full transparency on the specific strains and products that they are buying.”

About Digipath, Inc.

Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry’s best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath’s two business units are Digipath Labs and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.

For more information please visit http://www.Digipath.com/

Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, the demand for the Company’s products, governmental regulation of the cannabis industry, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.